These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 10171662)

  • 1. Evaluating managed mental health programs.
    Whitted GS; Kunnes R
    AAPPO J; 1993; 3(2):27-30. PubMed ID: 10171662
    [No Abstract]   [Full Text] [Related]  

  • 2. Seeking sane solutions: managing mental health and chemical dependency costs.
    Pflaum BB
    Empl Benefits J; 1991 Sep; 16(3):31-5, 40. PubMed ID: 10170846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mental health and substance abuse services in the era of health care reform.
    Boyer JF
    J Ambul Care Manage; 1993 Oct; 16(4):50-9. PubMed ID: 10171525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives. Substance abuse treatment not a priority for most health plans.
    Jordahl G
    Faulkner Grays Med Health; 1996 Jul; 50(28):suppl 1-4. PubMed ID: 10172671
    [No Abstract]   [Full Text] [Related]  

  • 5. Addressing addiction. Groups fight one-size-fits-all substance-abuse coverage.
    Kertesz K
    Mod Healthc; 1997 Jul; 27(28):84, 90. PubMed ID: 10173083
    [No Abstract]   [Full Text] [Related]  

  • 6. The impact of case management on psychiatry.
    Price J
    NAHAM Manage J; 1993; 18(3):10-1. PubMed ID: 10123909
    [No Abstract]   [Full Text] [Related]  

  • 7. Is conventional wisdom wrong? Coverage for substance abuse treatment under Medicaid managed care.
    Maglione M; Ridgely MS
    J Subst Abuse Treat; 2006 Jun; 30(4):285-90. PubMed ID: 16716842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance abuse treatment: outcomes of managed care techniques.
    Chung R; Filstead WJ
    Behav Healthc Tomorrow; 1995; 4(6):78-9, 58. PubMed ID: 10172617
    [No Abstract]   [Full Text] [Related]  

  • 9. The quiet epidemic.
    Ryan P
    Calif Hosp; 1993; 7(1):8-11. PubMed ID: 10171358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Michigan's substance abuse services: readiness for managed care.
    Stauffer M
    Behav Healthc Tomorrow; 1995; 4(4):57-8. PubMed ID: 10172404
    [No Abstract]   [Full Text] [Related]  

  • 11. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rehab centers run dry.
    Gleick E
    Time; 1996 Feb; 147(6):44-5. PubMed ID: 10172560
    [No Abstract]   [Full Text] [Related]  

  • 13. Dialogue. Should public sector mental health and substance abuse funding be merged?
    Moss S; Rawson RA; Posada H
    Behav Healthc Tomorrow; 1995; 4(6):40-6. PubMed ID: 10156802
    [No Abstract]   [Full Text] [Related]  

  • 14. The impact of managed care on addiction treatment: evaluating physicians' views and the value of health plan benefits.
    Galanter M
    J Addict Dis; 1999; 18(4):1-4. PubMed ID: 10631959
    [No Abstract]   [Full Text] [Related]  

  • 15. Mental health and substance abuse coverage under health reform.
    Arons BS; Frank RG; Goldman HH; McGuire TG; Stephens S
    Health Aff (Millwood); 1994; 13(1):192-205. PubMed ID: 8188135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marketing guidelines for providers of mental health and chemical dependency services--responding to changes in the packaging and purchase of behavioral health benefits.
    Oss ME
    Health Mark Q; 1993; 10(3-4):129-36. PubMed ID: 10128818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Packaging a better brand of mental health.
    Bell NN
    Bus Health; 1991 Jun; 9(6):75-8. PubMed ID: 10170772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mental health's contribution to the financial performance of a utilization management program.
    Hersch RG
    Manag Care Q; 1994; 2(2):71-8. PubMed ID: 10134006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managed care risk contracts and substance abuse treatment.
    Sturm R
    Inquiry; 2000; 37(2):219-25. PubMed ID: 10985114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of managed behavorial healthcare on the costs of psychiatric and chemical dependency treatment.
    Geraty R; Bartlett J; Hill E; Lee F; Shusterman A; Waxman A
    Behav Healthc Tomorrow; 1994; 3(2):18-30. PubMed ID: 10172255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.